Permanent Cardiac Pacemaker Implant with MCC DRG Reimbursement

Acute procedural optimization studies assessing different lead placement techniques, pacing modes, or implant approaches in patients undergoing initial permanent pacemaker implantation for symptomatic bradyarrhythmias or atrioventricular block. These trials enroll hospitalized adults who meet guideline criteria for device implantation and compare immediate periprocedural outcomes such as procedure duration, lead stability, acute complications (e.g., pneumothorax, hematoma), and in-hospital length of stay. Findings inform clinicians on safest, most efficient implant strategies and help payers anticipate resource utilization and complication-related costs for this high-acuity DRG.
Comparative effectiveness and device programming trials that evaluate single- versus dual-chamber pacemakers, different rate-response algorithms, or battery/lead technologies in patients with chronic conduction disease or sick sinus syndrome. These studies typically include both inpatient implants and short-term follow-up to measure symptom control, need for reintervention, infection rates, and medium-term readmissions. Results are relevant for guiding device selection, coding and reimbursement decisions, and predicting downstream costs associated with device longevity and complication profiles.
Post-discharge registry and outcomes research focused on long-term complications, infection surveillance, and readmission prevention in patients after permanent pacemaker implantation, including bundles for early follow-up, wound care protocols, and remote monitoring effectiveness. These observational cohorts capture real-world populations across ages and comorbidity burdens to quantify rates of device infection, lead malfunction, and unplanned rehospitalization within 30–90 days and beyond. Data support quality improvement initiatives, value-based payment models, and payer strategies to reduce preventable readmissions and manage chronic device-related costs.

Acute procedural optimization studies assessing different lead placement techniques, pacing modes, or implant approaches in patients undergoing initial permanent pacemaker implantation for symptomatic bradyarrhythmias or atrioventricular block. These trials enroll hospitalized adults who meet guideline criteria for device implantation and compare immediate periprocedural outcomes such as procedure duration, lead stability, acute complications (e.g., pneumothorax, hematoma), and in-hospital length of stay. Findings inform clinicians on safest, most efficient implant strategies and help payers anticipate resource utilization and complication-related costs for this high-acuity DRG.
Comparative effectiveness and device programming trials that evaluate single- versus dual-chamber pacemakers, different rate-response algorithms, or battery/lead technologies in patients with chronic conduction disease or sick sinus syndrome. These studies typically include both inpatient implants and short-term follow-up to measure symptom control, need for reintervention, infection rates, and medium-term readmissions. Results are relevant for guiding device selection, coding and reimbursement decisions, and predicting downstream costs associated with device longevity and complication profiles.
Post-discharge registry and outcomes research focused on long-term complications, infection surveillance, and readmission prevention in patients after permanent pacemaker implantation, including bundles for early follow-up, wound care protocols, and remote monitoring effectiveness. These observational cohorts capture real-world populations across ages and comorbidity burdens to quantify rates of device infection, lead malfunction, and unplanned rehospitalization within 30–90 days and beyond. Data support quality improvement initiatives, value-based payment models, and payer strategies to reduce preventable readmissions and manage chronic device-related costs.

OpenPayer

Summary & Overview

Permanent Cardiac Pacemaker Implant with MCC: Inpatient Reimbursement Overview

DRG 242 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes